Renaissance Capital logo

APLT News

US IPO Week Ahead: Just 1 biotech is on the calendar in a slow week for the IPO market

ETNB

After a busy week in the IPO market, just one biotech is scheduled to go public in the week ahead. NASH biotech 89bio (ETNB) plans to raise $85 million at a $225 million market cap. The company’s target indication represents a multi...read more

US IPO Weekly Recap: Fastly tops a 5-IPO Week

AVTR

After the busiest week of the year in the prior week, May 2019 continued to be active this past week with five IPOs and one SPAC offering. Three came to market with valuations of more than $1 billion, including fast-growing unicorns Luckin Coffee and Fastly, and...read more

Diabetic cardiomyopathy biotech Applied Therapeutics prices IPO at $10, well below the range

Applied Therapeutics logo

Applied Therapeutics, a Phase 2 biotech developing therapies for diabetic complications, raised $40 million by offering 4 million shares at $10, well below the range of $14 to $16. Applied Therapeutics plans to list on the Nasdaq under the symbol APLT. Citi,...read more

US IPO Week Ahead: China gets its coffee fix in a 7-IPO week

AGBAU

Seven IPOs are set to raise $4.85 billion in the week ahead, along with one blank check company. In addition to two REITs, a biotech, a small software maker, and a chemicals distributor, the line-up includes two high-growth unicorns: China-based coffee retailer...read more